These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27475634)

  • 1. A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines.
    Thiboonboon K; Santatiwongchai B; Chantarastapornchit V; Rattanavipapong W; Teerawattananon Y
    Appl Health Econ Health Policy; 2016 Dec; 14(6):659-672. PubMed ID: 27475634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.
    Luz A; Santatiwongchai B; Pattanaphesaj J; Teerawattananon Y
    Health Res Policy Syst; 2018 Feb; 16(1):4. PubMed ID: 29402314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
    Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
    JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
    Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
    Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting sustainable research partnerships: a mixed-method evaluation of a United Kingdom-Africa capacity strengthening award scheme.
    Dean L; Njelesani J; Smith H; Bates I
    Health Res Policy Syst; 2015 Dec; 13():81. PubMed ID: 26695073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.
    Newall AT; Jit M; Hutubessy R
    Pharmacoeconomics; 2014 Jun; 32(6):525-31. PubMed ID: 24791735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of rotavirus vaccines in low and middle-income countries.
    Sindhu KNC; Babji S; Ganesan SK
    Curr Opin Infect Dis; 2017 Oct; 30(5):473-481. PubMed ID: 28719399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social costs of road crashes: An international analysis.
    Wijnen W; Stipdonk H
    Accid Anal Prev; 2016 Sep; 94():97-106. PubMed ID: 27269998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping global evidence on strategies and interventions in neurotrauma and road traffic collisions prevention: a scoping review.
    M Selveindran S; Tango T; Khan MM; Simadibrata DM; Hutchinson PJA; Brayne C; Hill C; Servadei F; Kolias AG; Rubiano AM; Joannides AJ; Shabani HK
    Syst Rev; 2020 May; 9(1):114. PubMed ID: 32434551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
    Seuring T; Archangelidi O; Suhrcke M
    Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Surgery in Spinal Trauma: A Meta-Analysis of the World's Literature Comparing High-Income Countries to Low-Middle Income Countries.
    Chanbour H; Chen JW; Ehtesham SA; Ivey C; Pandey AK; Dewan MC; Zuckerman SL
    World Neurosurg; 2022 Nov; 167():e268-e282. PubMed ID: 35948226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.
    Baek Y; Ademi Z; Paudel S; Fisher J; Tran T; Romero L; Owen A
    Adv Nutr; 2022 Feb; 13(1):282-317. PubMed ID: 34510178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review.
    Tabyshova A; Hurst JR; Soriano JB; Checkley W; Wan-Chun Huang E; Trofor AC; Flores-Flores O; Alupo P; Gianella G; Ferdous T; Meharg D; Alison J; Correia de Sousa J; Postma MJ; Chavannes NH; van Boven JFM
    Chest; 2021 Feb; 159(2):575-584. PubMed ID: 33038390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported medication adherence instruments and their applicability in low-middle income countries: a scoping review.
    Khoiry QA; Alfian SD; van Boven JFM; Abdulah R
    Front Public Health; 2023; 11():1104510. PubMed ID: 37521968
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.